Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
4.66
0.25 (5.79%)
At close: Aug 15, 2025, 12:16 PM
Arcadia Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.16M | 4.24M | 3.94M | 5.5M | 3.32M | 6.52M | 10.61M | 13.48M | 23M | 20.64M | 22.72M | 21.23M | 24.55M | 28.68M | 35.53M | 43.98M | 32.85M |
Short-Term Investments | n/a | n/a | 2.64M | 2.6M | 5.18M | 5.12M | 5.09M | 5.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.09M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.06M | 4.06M | 4.13M | 4.33M | 3.34M | 3.52M | 1.8M | 1.48M | 925K | 932K | 1.15M | 1.3M | 2.81M | 2.67M | 3.72M | 4.07M | 4.31M |
Receivables | 3.58M | 3.07M | 2.71M | 2.6M | 760K | 514K | 304K | 630K | 923K | 1.29M | 2.73M | 3.85M | 2.77M | 1.37M | 1.45M | 1.15M | 1.11M |
Inventory | 1.28M | 904K | 835K | 978K | 1.83M | 1.96M | 2.66M | 3.16M | 2.59M | 2.57M | 3.34M | 3.27M | 3.23M | 4.43M | 5.45M | 3.9M | 2.66M |
Other Current Assets | 823K | 1.03M | 591K | 749K | 550K | 858K | 1.34M | 1.04M | 693K | 896K | 254K | 254K | 254K | 900K | 1.41M | 1.9M | 901K |
Total Current Assets | 8.85M | 9.24M | 10.71M | 12.43M | 11.64M | 14.97M | 20.01M | 23.34M | 27.2M | 25.4M | 30.03M | 30.06M | 31.5M | 35.39M | 43.83M | 50.92M | 56.61M |
Property-Plant & Equipment | 47K | 178K | 361K | 567K | 1.02M | 1.18M | 1.61M | 1.94M | 2.24M | 2.55M | 2.92M | 3.26M | 4.01M | 5.37M | 6.12M | 10.1M | 9.12M |
Goodwill & Intangibles | 39K | 39K | 39K | 39K | 39K | 39K | 40K | 40K | 40K | 40K | 373K | 386K | 471K | 484K | 5.55M | 5.72M | 758K |
Total Long-Term Assets | 4.14M | 4.28M | 4.53M | 4.93M | 4.4M | 4.73M | 3.46M | 3.46M | 3.21M | 3.52M | 4.44M | 4.95M | 7.3M | 8.53M | 15.39M | 19.88M | 14.19M |
Total Assets | 12.99M | 13.52M | 15.24M | 17.37M | 16.05M | 19.7M | 23.47M | 26.8M | 30.41M | 28.92M | 34.47M | 35.01M | 38.8M | 43.92M | 59.23M | 70.8M | 70.8M |
Account Payables | 1.9M | 703K | 1.69M | 1.56M | 1.73M | 801K | 2.6M | 2.78M | 2.79M | 905K | 2.75M | 3.39M | 3.44M | 1.41M | 5M | 5.19M | 3.42M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 46K | 33K | n/a | n/a | n/a | n/a | n/a | 64K | 51K | 63K | 63K |
Short-Term Debt | n/a | 155K | n/a | 563K | n/a | 852K | 924K | n/a | 1.01M | 1.01M | 986K | 994K | 1.04M | 1.07M | 1.17M | 2.1M | 1.85M |
Other Current Liabilities | 270K | 270K | 260K | 12K | 345K | -582K | -611K | 282K | -731K | -278K | -669K | -639K | -703K | -125K | -870K | -698K | -415K |
Total Current Liabilities | 2.22M | 2.56M | 2.33M | 2.7M | 2.88M | 3.59M | 3.88M | 4.09M | 4.1M | 4.21M | 4.05M | 4.74M | 4.81M | 5.04M | 6.49M | 7.65M | 5.62M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 78K | 87K | 96K |
Other Long-Term Liabilities | 1.87M | 4.73M | 2.76M | 3.09M | 2.66M | 3.26M | 3.84M | 4.45M | 8.86M | 2.81M | 4.13M | 2M | 2.04M | 5.46M | 9.88M | 14.65M | 14.16M |
Total Long-Term Liabilities | 1.87M | 4.73M | 2.76M | 3.1M | 2.69M | 3.41M | 4.18M | 4.98M | 9.62M | 3.81M | 5.4M | 3.5M | 3.75M | 7.68M | 12.52M | 20.47M | 19.48M |
Total Liabilities | 4.08M | 7.29M | 5.09M | 5.8M | 5.56M | 7M | 8.07M | 9.07M | 13.72M | 8.02M | 9.46M | 8.24M | 8.56M | 12.72M | 19M | 28.12M | 25.1M |
Total Debt | 21K | 155K | 346K | 574K | 822K | 1.01M | 1.27M | 1.52M | 1.77M | 2.02M | 2.25M | 2.49M | 2.75M | 3.29M | 3.81M | 7.92M | 7.17M |
Common Stock | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 63K | 63K | 63K | 63K | 63K | 62K |
Retained Earnings | -276.28M | -278.88M | -274.81M | -273.2M | -274.26M | -271.84M | -268.99M | -266.42M | -267.24M | -257.86M | -253.62M | -250.75M | -246.97M | -226.49M | -217.2M | -215.03M | -209.77M |
Comprehensive Income | n/a | n/a | 117K | 81K | 161K | 101K | 87K | 21K | n/a | n/a | n/a | -0.00 | 0.00 | 0.00 | -24K | -12K | -5.12M |
Shareholders Equity | 8.9M | 6.22M | 10.29M | 11.7M | 10.62M | 12.84M | 15.54M | 17.87M | 16.82M | 21.03M | 25.07M | 26.81M | 30.26M | 31.09M | 39.84M | 41.64M | 44.5M |
Total Investments | n/a | n/a | 2.64M | 2.6M | 5.18M | 5.12M | 5.09M | 5.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.09M |